Vaccines
PART OF NEXTGEN BIOMED 2025
12 - 14 March 2025 | London, UK
NextGen Biomed 2025
Gain valuable insights into novel nucleotides, biologics & other vaccine platforms. Presentations will cover modern vaccine technologies such as mRNA and new DNA vaccines, advanced antigen development and live-attenuated and inactivated vaccine platforms.
Discover the latest innovations in vaccine analytical testing & stability. Take a deep dive into gene expression testing, lab automation for mRNA vaccines screening and pioneering computational approaches, methods & tools such as codon optimization design and UTR optimization.
Hear key opinion leaders discussing preclinical innovation & clinical development for mRNA vaccines. Learn about advancements in biomarker studies from mRNA vaccines evaluation, new cell-specific targeting approaches and pandemic preparedness.
Devised with the help of our esteemed advisory board. Presentations will also look at lessons learnt from the SARS-CoV2 mRNA vaccine campaigns, vaccine stability testing techniques and immune-reactogenicity of mRNA vaccines.
leading pharma, biotech, regulatory & academic delegates
Agenda at a Glance
Vaccines
Three immersive tracks across three days
Day One: Nucleotides, Biologics & Other Vaccine Platforms for Infectious Diseases & Antigen Development
Day Two: Vaccine Analytical Testing & Stability
Day Three: Preclinical Innovation & Clinical Development for mRNA Vaccines
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.